Keeping tabs on Covid-19: BioNTech buys GMP-certified facility to boost vaccine…
The Pharma Data
SEPTEMBER 18, 2020
The Marburg facility is expected to start the production of mRNA formulation for a Covid-19 vaccine in the first half of 2021, pending regulatory authorization or approval.
Let's personalize your content